Podcasts TV Interviews

Dr. Harsha Rajasimha joins TechBlick Health Series on Panel Discussion with other industry experts.

Remote Monitoring Panel Discussion | Dr. Harsha Rajasimha Joins TechBlick Health Series 2024 Panel

February 20, 2024
The conversation in the panel explores how AI can revolutionize contemporary clinical trials, highlighting the obstacles stemming from the absence of integrated platforms that consolidate AI solutions for patient recruitment, data management, and analytics to enhance clinical operations. Additionally, it underscores the potential of remote visits to modernize trials and enhance data collection, particularly for rare diseases, while also addressing issues of bias in datasets concerning race, ethnicity, and gender.
Joining the panel for a hot debate on remote patient monitoring, our Founder & CEO, Dr. Harsha K Rajasimha, Ph.D., explains the importance of remote patient monitoring through digital health channels and, avoiding the in-person approach to brick-and-mortar clinical sites.
For more, Visit Here.

This is an interview by WFMJ News with our Founder and CEO, Dr. Harsha Rajasimha

Role of Global Patient Registry in Sickle Cell Disease Trials | WFMJ TV Talks To Dr. Harsha Rajasimha

February 4, 2024
Sickle cell disease, which affects many people in Africa, is a major concern for medical professionals. Thankfully, the FDA has recently approved two therapies in the US, but they are expensive and inaccessible for many patients. Global patient registries are needed to make these treatments affordable and available worldwide.
Our Founder & CEO, Dr. Harsha K Rajasimha, Ph.D. believes now is the ideal moment to collaborate on common interests and unite the US and the Indian subcontinent. This will help alleviate the burden and make these therapies accessible worldwide.
Watch the complete interview by WFMJ TV: from here.

This is a interview hosted by Polite On Society with Dr. Harsha Rajasimha.

Bridging the Diversity Disparity: Global Patient Registries Revolutionize Sickle Cell Research | Interview By Polite On Society

January 25, 2024
Modern clinical trials are witnessing a significant challenge in the lack of inclusivity, particularly in regional registries. These registries often fail to capture the global population's diverse demographics and genetic backgrounds, which hinders the comprehensive understanding of disease heterogeneity and natural history. This limitation restricts the development of effective healthcare strategies that cater to the needs of all affected communities.
Responding to this trending issue, our Founder & CEO, Dr. Harsha K Rajasimha, Ph.D., emphasizes the necessity for global collaboration and government cooperation to rectify biased datasets and ensure accessibility and affordability of advancements in gene therapy. He advocates for pooling diverse datasets, establishing inclusive regulatory frameworks, fostering knowledge exchange, and creating funding mechanisms to address healthcare disparities and promote equitable access to medical innovations.
Further, continuing his talk with Polite On Society on 'Bridging the Diversity Disparity: Global Patient Registries Revolutionize Sickle Cell Research' he adds, "Inclusivity in clinical research is paramount for addressing the complexities of diseases like sickle cell disease and ensuring that healthcare interventions are effective and accessible to all affected populations."
For more, Visit Here.

Revolutionizing Investigator - Jeeva Trials

Revolutionizing Investigator-Initiated Trials | DocWire News Interviews Dr. Harsha Rajasimha, Ph.D.

December 27, 2023
When comparing sponsor-initiated trials to Investigator-Initiated Trials (IITs), the budget poses a major constraint in various research aspects such as data management and patient engagement.
Our Founder & CEO, Dr. Harsha K Rajasimha,Ph.D. shares his perspective with DocWire News on this matter, stating that selecting the appropriate platform and implementing #decentralizedtrials correctly from the protocol design phase can greatly reduce costs and alleviate logistical burdens that patients wish to avoid during their participation in clinical trials.
Additionally, he mentions that Jeeva Clinical Trials Inc.'s Protocol to Publication initiative, supported by its integrated eclinical platform, can effectively address these challenges. Learn more here: Click Here.

Managed Healthcare Executive Podcast Interview | Jeeva Trials

Bridging the Diversity Gap in Rare Disease Clinical Trials with Dr. Harsha Rajasimha, Ph.D.

November 8, 2023
As the clinical trials industry is still scrambling with diversity concerns, FDA's Racial and Ethnic Diversity Plan is now emphasizing biopharmaceutical sponsors to embrace and accelerate the clinical trials equitably.
Propelling his voice towards removing disparities in diversity and ethnicity, our Founder and CEO, Dr. Harsha K Rajasimha, Ph.D., calls to foster the gaps arising in clinical research. While discussing the topic, “Bridging the Diversity Gap in Rare Disease Clinical Trials”, he emphasized the importance of closing the gaps in these trials, as it can benefit all patients and clinical stakeholders.
He also believes that early detection and diagnosis of rare diseases like ALS, Cystic Fibrosis, Thalassemia, Hemophilia, and others can significantly improve patient outcomes and prognosis.
For more, listen to this podcast from Managed Healthcare Executive:
Visit Here.

KJAG Radio Interview - Podcasts | Jeeva Trials

Hot Talk With KJAG Radio on "Impact of IRA on Drug Development & Price Negotiations" | Jeeva Clinical Trials

October 24, 2023
Only 5% of rare diseases have appropriate treatments, leaving 95% with inadequate solutions. While the IRA benefits patients with rare diseases, it poses a significant challenge for emerging biopharmaceutical companies struggling in the initial development phase of clinical trials.
Dr. Harsha K Rajasimha strongly believes that the lengthy and costly process of developing a single drug from biomarker discovery to market availability, which takes almost a decade and two and a half billion dollars, can hinder revenue pipeline due to the act stifling medical innovation on a large scale.
Patient advocacy groups play a crucial role in rare disease drug development. They propel their voice to amend the IRA and seek incentives for early-stage drug repurposing to make it available to rare disease patients quickly. It is time to act and ensure that rare disease patients receive the appropriate treatments they deserve.
To listen the podcast interview from KJAG Radio: Click Here.

KRDO Podcast Interview

IRA Stifling Innovation In Medical Research | KRDO News Talk With Dr. Harsha Rajasimha

October 13, 2023
KRDO News Radio has recently aired the Interview of our Founder & CEO, Dr. @HarshaRajasimha on the topic "Inflation Reduction Act (IRA) is stifling innovation in medical research" at their Radio Channel, KRDO NewsRadio. Jeeva Trials is pleased to announce about this podcast.
To learn more, Visit Here.

Webinar at International Conference on Orphan Drugs and Rare Diseases | Dr. Harsha Rajasimha

International Conference on Orphan Drugs and Rare Diseases | Webinar By Dr. Harsha Rajasimha

August 17, 2023
Our Founder and CEO, Dr. @HarshaRajasimha, as a keynote speaker, presented a webinar at the International Conference on Orphan Drugs and Rare Diseases. Attending through online mode, he discussed the complete patient journey in rare diseases and their challenges.
Also, he highlighted the potential of decentralized trials in accelerating their treatment. Moreover, he emphasized the remarkable efficiency and capabilities of Jeeva's unified eClinical platform in speeding up orphan drug research.
To learn more, Visit Here

Dr. Harsha Rajasimha Talks on Exclusion of Women in Clinical Trial with Fox 32 Chicago Channel

Dr. Harsha Rajasimha's Concern on Exclusion of Women In Clinical Trials | Interview with Fox 32 News

September 20, 2023
FOX 32 WFLD-TV has recently aired the Interview of our Founder & CEO, Dr. @HarshaRajasimha on the topic "Women excluded in clinical trials leaves treatment geared toward men." at their News Channel, Fox 32 Chicago. Jeeva Trials is pleased to announce about this podcast.
To learn more, Visit Here.

Pharmacy Focus Podcast - Jeeva Trials

Dr. Harsha Rajasimha's Interview With Pharmacy Times on "Women in Clinical Trials, Decentralized Clinical Trials" | Pharma Focus Podcast - Episode 226

Sept 8, 2023
Phamacy Times has recently aired the interview of our Founder and CEO, Dr. @HarshaRajasimha at their podcast channel, "Pharma Focus Podcast". This interview discussed the significance of including women and minority groups in clinical trials and how decentralized clinical trials can be utilized to address gender disparities. To learn more, Visit Here.

Once Upon Gene

Accelerating Clinical Research – Harsha Rajasimha, Founder and CEO of Jeeva Trials | ONCE UPON A GENE - EPISODE 071

Feb 25, 2021
Health Podcast Network has recently aired the Interview of our Founder & CEO, Dr. @HarshaRajasimha on the topic ""Accelerating Clinical Research" at their Podcast Channel @Once Upon A Gene. @Jeevatrials is pleased to announce about this podcast. To learn more, Visit Here.

Dr. Harsha Karur Rajasimha Interviewed By Rich Lenz on _Clinical Trial Dispariti

Dr. Harsha Rajasimha Interviewed By Rich Lenz on "Clinical Trial Disparities" | The Oklahoma News Report - KETA-TV

August 18, 2023
The Oklahoma News Report - KETA-TV has recently aired the interview on Clinical Trials Disparities. In this interview our Founder and CEO, Dr. @HarshaRajasimha discusses the reduced participation of women and minorities in clinical trials, how decentralized clinical trials can help alleviate this disparity, and the associated risks that arise due to this imbalance.
Watch full episode

The Rare Disease Diversity Coalition Webinar

The Rare Disease Diversity Coalition Webinar

Dec 15, 2022
Best of Times has recently been aired on their Radio FM Channel @Jeevatrials is pleased to announce that an interview between Dr. @Harsharajasimha and Best of Times has recently been aired. It provides some great insights to the listeners on Clinical Trials. It went live on Oct 29, 2022 @ 9:05am on 710 KEEL.

The Rare Disease Diversity Coalition Webinar

Best Of Times Has Recently Been Aired On Their Radio FM Channel

October 29, 2022
Best of Times has recently been aired on their Radio FM Channel @Jeevatrials is pleased to announce that an interview between Dr. @Harsharajasimha and Best of Times has recently been aired. It provides some great insights to the listeners on Clinical Trials. It went live on Oct 29, 2022 @ 9:05am on 710 KEEL.

Harsha Rajasimha Interview

Jeeva Clinical Trials Inc. On CEO-CFO Magazine

November 7, 2022
@Jeevatrials is pleased to announce that an interview of Dr. @Harsharajasimha has recently been published in CEO-CFO Magazine on their Human- centric eClinical Platform that enables better remote monitoring Clinical Trials Worldwide.

BlueCloudTV Video Interview

BlueCloudTV Video Interview

August 16, 2022
BlueCloudTV Video Interview about Jeeva eClinical Cloud, its genesis, the story behind the technology, and the exciting future for faster, more diverse clinical trials.
Watch full episode

I Dont Care Podcast

I Don't Care PodCast

January 15, 2022
Kevin Stevenson from I Don't Care Podcast of MarketScale hosted Jeeva CEO Dr. Harsha Rajasimha in a candid conversation on the true cost of delays in clinical trials. 85% of all clinical trials are delayed by at least 30 days due to poor enrollment. What's the true cost? What are the challenges associated with global clinical research, lack of diversity, equity, and access? Rajasimha shares Jeeva's unique approach to addressing these challenges.
Watch full episode

Purple Project Logo

Purple Project PodCast

January 07, 2022
Dino Verrelli from Project Purple hosted Jeeva CEO Harsha Rajasimha, in his podcast focused on accelerating cures for pancreatic cancer. A candid conversation between two patient advocates.
Watch full episode

Dad to Dad 175

Dad to Dad 175 - Dr. Harsha Rajasimha, Founder of Jeeva Trials, Lost A Child To Edwards Syndrome

November 12, 2021
Harsha Rajasimha, Founder of Jeeva Trials, spoke with David Hirsch, Founder of 21st Century Dads Foundation and leader of the Special Fathers Network (SFN). A candid conversation between two dads on the experience of losing a child and coping with it.
Watch full episode

Harsha Rajasimha Joined Kamala Maddali And Scott Schliebner For an Exciting Discussion On Distributed Clinical Trials

In this episode 8 of 21 in 21 series hosted by Sanjay Joshi, our CEO Harsha Rajasimha joined Kamala Maddali and Scott Schliebner for an exciting discussion on distributed clinical trials

November 08, 2021
In this episode 8 of 21 in 21 series hosted by Sanjay Joshi, our CEO Harsha Rajasimha joined Kamala Maddali and Scott Schliebner for an exciting panel discussion on decentralized clinical trials.
Watch full episode

EURweb Logo

A Conversation Between EURweb.com (Everything Urban Radioscope) and our CEO Dr. Harsha Rajasimha on the Dire Need to Diversify Clinical Trials | VIDEO

November 05, 2021
Ricardo Hazell of @EURweb.com sat down with our CEO Dr. Harsha Rajasimha to discuss his perspectives on the Dire Need to Diversify Clinical Trials. “There are clinical research projects or clinical trials which can help patients living with chronic or rare diseases anywhere in the world. But 80 percent of all clinical trial participants continue to be Caucasian, most of them male and middle-aged from an affluent background.” How can digital health and SaaS technology help address this challenge?
Watch full episode

Don Davis Podcast

In this episode of Life Science Success, Donald L. Davis spoke with Harsha Rajasimha, CEO of Jeeva Trials

November 03, 2021
In this episode of Life Science Success, we are speaking with Harsha Rajasimha. Harsha is a Social Entrepreneur committed to applying his 15+ years of distinguished experience in healthcare and life sciences consulting, precision medicine, genomics of rare diseases, and cancer to help accelerate drug R&D and digital therapeutics.
Watch full episode

Rare Care

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Harsha K. Rajasimha, PhD, in Herndon, Virginia.

October 27, 2021
Dr. Harsha Rajasimha, CEO of Jeeva Trials, has also founded a couple of non-profit organizations focused on improving the diversity, equity, and inclusion (DE&I) of patients in clinical trials worldwide.
Listen to the full episode

Connecting Researchers & Patients

"Connecting researchers & patients, East & West to accelerate therapy access" - H. Rajasimha, PhD

September 27, 2021
This lecture was given at the Defeat MSA Alliance & MSA United All-Community MSA Conference (Sept 24-Oct 2, 2021)
Watch full video

Harsha Rajasimha

Disruption Interruption Podcast by Karla Jo Helms of JOTOPR: Clinical Trials by Innovator Dr. Harsha Rajasimha of Jeeva

September 20, 2021
Disruption Interruption podcast host and veteran communications disruptor, Karla Jo Helms of JoTo PR Disruptors, interviewed Dr. Harsha Rajasimha, Founder & CEO of Jeeva Clinical Trials Inc.—and uncovered how he has utilized his experiences and education to bring disruption into the pharmaceutical and healthcare industry by listening to all stakeholders involved in the process of clinical trials.

Calling For Diversity In Clinical Trials

Newswatch 16 WNEP-TV: Calling for more diversity in clinical trials

September 15, 2021
Medical experts say this health crisis has made it all the more clear how important diversity is in clinical trials. “The effect is significant in terms of science, medicine, and also the population that we are all trying to serve," said Dr. Harsha Rajasimha, founder and CEO of Jeeva Clinical Trials Inc.
Watch the TV Interview

Management Blueprint Podcast with Steve Preda

Management Blueprint Podcast with Steve Preda: Building a world-class company that helps researchers accelerate clinical studies

August 30, 2021
Pinnacle Business Guide's Steve Preda interviewed our founder and CEO Dr. Harsha Rajasimha about his journey building and scaling a Software as a Service (SaaS) business that helps patients, clinical researchers, biopharma sponsors, and non-profit research organizations.

2021 NDF Speaker Series

2021 NDF Speaker Series: Dr. Harsha Rajasimha, CEO and Founder of Jeeva Clinical Trials Inc. discusses patient databases.

July 17, 2021
Neuromuscular Disease Foundation (NDF) mission is to enhance the quality of the lives of people living with GNE Myopathy through advocacy, education, outreach, and funding critical research focused on treatments and a cure.
Watch full episode

Jeeva will be at the RARE Advocacy Summit 2021

As a proud member of the Global Genes Corporate Council, Jeeva will be at the RARE Advocacy Summit 2021

February 27, 2021
The Department of Science and Technology (DST) center for policy research at the Indian Institute of Science (IISc) hosted a panel discussion during Rare Disease Week 2021 on Open data for Rare diseases: An Indian Perspective Panelists: Prof. Vijay Chandru, Faculty at the Centre for BioSystems Science and Engineering at IISc. Prof. Arkalgud Ramaprasad, Director of the Ramaiah Public Policy Center, Bengaluru, India. Dr. Harsha Rajasimha, Founder and CEO, Jeeva Clinical Trials Inc., Tysons Corner, VA, USA Dr. Shilpi Bhattacharya, Professor of Law at Jindal Global Law School, O.P. Jindal Global University, India
Watch full episode

Decentralizing Clinical Research for Rare Diseases at Scale with Harsha K Rajasimha

MissionMatters Podcast with Adam Torres: Decentralizing Clinical Research for Rare Diseases at Scale

November 18, 2020
Decentralizing clinical research can have many benefits such as cutting costs. In this episode, Adam Torres and Harsha K. Rajasimha, Founder and CEO of Jeeva Trials and Founder and Chairman of Indo US Organization for Rare Diseases, explore the benefits and process of decentralizing clinical research.
Source: MISSION MATTERS
Listen to the podcast

Decentralizing Clinical Trials with Harsha Rajasimha from Jeeva Informatic Systems

Podbean Podcast: Wait How do you spell that rare disease? Decentralizing Clinical Trials with Harsha Rajasimha from Jeeva Clinical Trials Inc.

July 7, 2020
In this interview from Rare Disease Day at the NIH, Ilana Bean talks to Dr. Harsha Rajasimha, the CEO and founder of Jeeva Clinical Trials Inc. about how clinical trials can change to better meet rare patient needs-- in the US, India, and across the world. Source: Wait How Do You Spell That?
Listen to the podcast

Bringing Clinical Trials to Patients

RareCast By Global Genes with Daniel Levine: Bringing Clinical Trials to Patients

February 12, 2020
Conducting rare disease clinical trials can be challenging because of small and geographically dispersed groups of patients who may face difficulties in traveling to trial sites. Regulatory requirements for cell and gene therapies, even if only administered once, require long-term follow-ups that extend for many years and provide an ongoing burden for patients. Jeeva Clinical Trials Inc. is seeking to address those challenges through it harnessing of digital health technologies to bring the trial to the patient. We spoke to Harsha Rajasimha, founder and CEO of Jeeva, about the challenges of conducting rare disease clinical trials, the potential of digital health technologies to address those issues, and how ready regulators and sponsors may be to embrace these technologies to transform the way they conduct clinical trials today.
Source: RARECast by Global Genes
Listen to the podcast

Dr. Harsha Karur Rajasimha Interviewed By Rich Lenz on _Clinical Trial Dispariti

Dr. Harsha Rajasimha Interviewed By Rich Lenz on "Clinical Trial Disparities" | The Oklahoma News Report - KETA-TV

August 18, 2023
The Oklahoma News Report - KETA-TV has recently aired the interview on Clinical Trials Disparities. In this interview our Founder and CEO, Dr. @HarshaRajasimha discusses the reduced participation of women and minorities in clinical trials, how decentralized clinical trials can help alleviate this disparity, and the associated risks that arise due to this imbalance.
Watch full episode